 |
Open for inclusion |
Rituximab with or without Ibrutinib for untreated patients with advanced follicular lymphoma in need of therapy. A randomized double-blinded Phase II trialCancer type: Lymphoma Phase: II Principal Investigator: Østenstad Bjørn Keywords: Norway, Oslo, Adult patients with follicular lymphoma Status: Open for inclusion Link to Clinicaltrials.gov: https://clinicaltrials.gov/ct2/show/NCT02451111?term=2015-001487-19&rank=1 |